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PURPOSE. Sorsby fundus dystrophy (SFD) is a rare, late-onset
macular dystrophy caused by mutations in the tissue inhibitor
of metalloproteinases-3 (TIMP3) gene. The known mutations
introduce potentially unpaired cysteine residues in the C ter-
minus of the protein and result in the formation of higher-
molecular-weight protein complexes of as yet unknown com-
position and functional consequences in the pathologic course
of SFD. To facilitate in vivo investigation of mutant TIMP3, the
authors generated a knock-in mouse carrying a disease-related
Ser156Cys mutation in the orthologous murine Timp3 gene.
METHODS. Site-directed mutagenesis and homologous recombi-
nation in embryonic stem (ES) cells was used to generate
mutant ES cells carrying the Timp3S156C allele. Chimeric ani-
mals were obtained, of which two displayed germline trans-
mission of the mutated allele. Molecular genetic, biochemical,
electron microscopic, and electrodiagnostic techniques were
used for characterization.
RESULTS. At 8 months of age, knock-in mice showed abnormal-
ities in the inner aspect of Bruch’s membrane and in the
organization of the adjacent basal microvilli of the retinal pig-
ment epithelium (RPE). Changes resembling those in the mu-
tant animals were also present to some extent in normal litter-
mates, but only at an advanced age of 30 months. Long-term
electrodiagnostic recordings indicated normal retinal function
throughout life. The biochemical characteristics of the mutant
protein appear similar in humans and knock-in mice, suggest-
ing common molecular pathways in the two species. The
localization of the mutant protein in the eye is normal, al-
though there is evidence of increased Timp3 levels in Bruch’s
membrane of mutant animals.
CONCLUSIONS. The knock-in mice display early features of age-
related changes in Bruch’s membrane and the RPE that may
represent the primary clinical manifestations of SFD. In addi-
tion, our immunolabeling studies and biochemical data sup-
port a model proposing that site-specific excess rather than
absence or deficiency of functional Timp3 may be the primary
consequence of the known Timp3 mutations. (Invest Ophthal-
mol Vis Sci. 2002;43:2732–2740)
Sorsby fundus dystrophy (SFD) is a rare hereditary degener-ative disease of the retina. The condition generally mani-
fests in the fourth decade of life, with rapid loss of central
vision followed by progressive loss of peripheral vision, leading
ultimately to blindness.1 A regular finding is the abnormal
deposition of lipofuscin-like material and thickening of Bruch’s
membrane.2,3 Over the course of the disease, there is subreti-
nal neovascularization, peripherally extending atrophy of the
retinal pigment epithelium, and later atrophy of the choriocap-
illaris. Despite its rarity, the autosomal dominant SFD has at-
tracted much attention, because the clinical features greatly
overlap with those of age-related macular degeneration (AMD),
a frequently occurring retinal disease of complex origin ac-
counting for most of the late-onset blindness in individuals in
developed countries.4
In 1994, affected individuals from two unrelated SFD fami-
lies were found to harbor heterozygous point mutations in the
tissue inhibitor of metalloproteinases-3 (TIMP3) gene.5 TIMP3
is a member of a family of four secreted proteins (TIMP1 to
TIMP4) that were originally identified as inhibitors of the ma-
trix metalloproteinases (MMPs),6 but were recently found also
to interact with other members of the zinc-dependent protease
(e.g., with a disintegrin and metalloproteinase with throm-
bospondin motifs ADAM or ADAMTS) family.7,8 Because the
various groups of proteolytic enzymes are involved in the
degradation of the extracellular matrix (ECM), the interactions
between the TIMPs and the proteases ultimately regulate the
composition of the ECM, consequently affecting cell growth
and survival, migration, and function.9,10 Similar to other TIMP
proteins, TIMP3 consists of two domains. The N-terminal do-
main is involved in MMP inhibition, whereas the C-terminal
domain binds the ECM.11 All TIMP3 mutations described in
patients with SFD to date reside in or affect exon 5 of the gene
and are predicted to generate unpaired cysteine residues
within the C-terminal portion of the protein.5,12–16 Heterolo-
gous expression of mutant TIMP3 in COS7 cells demonstrates
that at least three of these mutations result in proteins that
retain inhibitory activity and localize to the ECM but form
high-molecular-weight complexes, the nature and conse-
quences of which have not yet been established.11,16
A better understanding of the biological role of mutant
TIMP3 in SFD would be greatly facilitated by the use of a model
experimental system. We report the generation of mice carry-
ing a Timp3 alteration orthologous to a mutation found in a
large SFD pedigree.12
MATERIALS AND METHODS
Site-Directed Mutagenesis and Construction of a
Targeting Vector
Recombinant phage clones containing the Timp3 locus were isolated
from a 129/SvJ mouse genomic DNA library constructed in lambda FIX
II (Stratagene, La Jolla, CA). The Ser156Cys mutation was introduced
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into a 2.7-kb HincII fragment with PCR primers mutl56bom (5-GGC
GTA GTG TTT GCA CTG ATA GCC AGG GTA CCC-3) and mut156top
(5-GGG TAC CCT GGC TAT CAG TGC AAA CAC TAC GCC-3).
Similarly, an artificial SacI site was generated in intron 4 of Timp3 with
primers MutSacl (5-GCC TGC CAT GGT GAG CTC CCC TAA CTG TGG
C-3) and MutSac2 (5-GCC ACA GTT AGG GGA GCT CAC CAT GGC
AGG C-3). Ligation of restriction fragments XbaI-HincII (1.3 kb),
HincII-SacI (1.7 kb), SacI/SacI neoflox-8-SacI (1.3 kb), and SacI-SphI
(1.3 kb) resulted in the final targeting construct (Fig. 1a). Linearization
of the plasmid was achieved with SfiI.
Homologous Recombination in ES Cells and
Generation of Germline Chimeras
After G418 selection, 400 ES clones were analyzed by Southern hybrid-
ization of BamHI-digested DNA to a 3 external probe (Figs. 1a, 1b).
Cre recombinase was transiently expressed in two targeted ES cell lines
to mediate excision of the loxP flanked neor cassette. Mutant ES cells
carrying the Timp3S156C allele were injected into C57BL/6 blastocysts,
as described.17 Two male chimeras (numbers 15 and 17) were bred to
C57BL/6 females to test for germ line transmission. F1 and F2 proge-
nies of 129/Sv and hybrid C57BL/6 129/SvJ background were further
analyzed. All experimental procedures were conducted according to
the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research.
Northern Blot Analysis and RT-PCR
Total RNA isolation from mouse eyecup and kidney and Northern blot
analysis were performed as described.18 The hybridization probe en-
compasses the coding sequence of mouse Timp3 and was generated
by RT-PCR with primers muTimp3for (5-GGC TCT TCC ATG ACT CCC
TGG CTT GGG CTT-3) and muTimp3rev (5-TGC TCT TCG AAG CTA
TCA GGG GTC TGT GGC GTT-3). Sequencing of the wild-type and
mutant murine Timp3 exon 5 was done with primers mTimp3_ex5F
(5-TGC AAG ATC AAG TCC TGC T-3) and mTimp3_ex5R (5-GGT
GAG GTG GGG CAG GTC T-3).
SDS-Polyacrylamide Gel Electrophoresis, Western
Blot Analysis, and Immunofluorescence Labeling
Eyecups were homogenized in PBS buffer. Quantitation of protein
extracts was performed by Coomassie staining and subsequent visual
inspection or by the protein assay based on the method of Bradford
(Bio-Rad Laboratories, Munich, Germany; Ref. 19). Extracellular matrix
was isolated from fibroblast cell cultures of patients with SFD carrying
a heterozygous Ser156Cys12 or Ser181Cys5 TIMP3 mutation or from
Timp3/, Timp3/S156C, and Timp3S156C/S156C mice after removal of
cells with trypsin, washing in PBS buffer containing phenylmethylsul-
fonyl fluoride (PMSF; 80 g/mL) and -caproic acid (1 mg/mL) and
dissolving in ECM buffer (100 mM Tris-HCl [pH 6.8], 10% glycerin, and
1% SDS). Protein samples were added to a 1:1 volume of a solution
containing 125 mM Tris-HCl (pH 6.8), 2% SDS, 10% sucrose, 0.02%
bromophenol blue in the presence or absence of 5% -mercaptoetha-
nol (-ME).
For immunodetection, 16-amino-acid peptides (human: RGWAPP-
DKSIINATDP; mouse: RGWAPPDKSISNATDP) corresponding to amino
acids 196-211 of human and mouse TIMP3 were conjugated to keyhole
limpet hemocyanin and used to immunize New Zealand White rabbits
(human: phAB#57; mouse: pmAB#50). The polyclonal antibodies were
purified on a protein A affinity column and used in a 1:1000 dilution.
In addition, polyclonal rabbit antisera directed against RPE-specific
protein, 65 kDa (RPE65),20 interphotoreceptor retinoid-binding pro-
tein (IRBP),21 cellular retinaldehyde-binding protein (CRALBP),22 and
arrestin23 were used.
For immunofluorescence labeling, retinal sections were mounted
(Tissue-Tek 4583; Sakura Finetek Europe, Zoeterwoude, The Nether-
lands), cryosectioned (12 m), and collected on polylysine-treated
slides. The sections were incubated with the primary antibody for 2
hours at 37°C. The control sections were labeled with the same
antibody but in the presence of the 16-amino-acid Timp3 peptide
antigen (100 g/mL). The sections were washed in PBS buffer con-
taining 0.05% Tween 20. The secondary antibody (swine anti-rabbit
FITC-labeled; Dako A/S, Glostrup, Denmark) was used in a dilution of
1:1000. The sections were incubated for 1 hour at 37°C, washed in PBS
buffer containing 0.05% Tween 20, mounted in antifade medium
(Vectashield; Vector Laboratories, Burlingame, CA) and analyzed using
fluorescence microscopy (Carl Zeiss, Oberkochen, Germany).
Scanning Laser Ophthalmoscopy
Fundus imaging was performed with scanning laser ophthalmoscopy
(SLO) using a scanning frequency of 50 Hz and an infrared wavelength
of 780 nm (Rodenstock Instruments, Du¨sseldorf, Germany). A standard
20-D ophthalmoscope lens (Volk Optical, Mentor, OH) was inserted in
the optical pathway between the SLO and the eye.24,25 The confocal
diaphragm of the SLO facilitates imaging in different planes of the
FIGURE 1. Introduction of the Ser156Cys mutation into the mouse
Timp3 locus. (a) Targeting construct and predicted structure of the
targeted allele. The Ser156Cys mutation in exon 5 was cotransferred
with the neor gene (inserted into intron 4 of Timp3 close to the
acceptor splice site of exon 5 flanked by loxP sites) through homolo-
gous recombination in ES cells. Before microinjection into C57BL/6
blastocysts, targeted ES cells were treated in culture with Cre recom-
binase to excise the neor gene. B, BamHI, E3 to E5 corresponds to
exons 3 to 5 of Timp3. (b) Southern blot analysis of BamHI-digested
DNA isolated from wild-type (/), heterozygous (/S156C), and
homozygous (S156C/S156C) mice, demonstrating the accuracy of the
targeting event by the presence of a 3.3-kb BamHI fragment after
hybridization with the external 3 probe. (c) Northern blot analysis of
total kidney RNA reveals the presence of the three known isoforms of
Timp3 in wild-type, Timp3/S156C, and Timp3S156C/S156C mice. The
filter was reprobed with -actin to test for RNA integrity and loading
(d) Western blot analysis of ECM protein extracts obtained from
fibroblast cultures of wild type, Timp3/S156C, and Timp3S156C/S156C
mice using murine antibody pmAB#50. The Timp3 protein was present
in wild type and ECM preparations from heterozygous and homozy-
gous fibroblast cell lines.
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posterior pole which can be viewed sequentially by varying the focus
from 15 D (surface) to 5 D (RPE).
Electroretinography
ERGs were obtained according to previously described procedures.26
In brief, mice were dark-adapted overnight (at least 6 hours) before the
experiments and their pupils dilated. They were anesthetized by sub-
cutaneous injection of ketamine (66.7 mg/kg), xylazine (11.7 mg/kg),
and atropine (1 mg/kg). Silver needle electrodes served as reference
(forehead) and ground (tail), and rings made from 0.5 mm2 gold wire
served as monopolar corneal electrodes. ERGs were recorded from
both eyes simultaneously. Band-pass filter cutoff frequencies were 0.3
and 300 Hz. Single-flash recordings were obtained both under dark-
adapted (scotopic) and light-adapted (photopic) conditions. Light ad-
aptation before the photopic session was achieved with a background
illumination of 30 cd/m2 presented for 10 minutes. Flash stimulus
intensities were increased under scotopic conditions from 104 cd/sec
 m2 to 25 cd/sec  m2, divided into 10 steps of 0.5 and 1 log cd/sec 
m2, and under photopic conditions from 103 cd/sec  m2 to 25 cd/sec
 m2, divided into seven steps of 0.5 and 1 log cd/sec  m2. Ten
subsequent responses were averaged with an interstimulus interval
(ISI) of 5 or 17 seconds (for 1, 3, 10, and 25 cd/sec  m2).
Electron Microscopy
For electron microscopy, light-adapted eyes were enucleated and
hemisected along the ora serrata. The posterior eyecups were imme-
diately immersed overnight in ice-cold fixative (1% paraformaldehyde,
2.5% glutaraldehyde in 0.05 M phosphate buffer, [pH 7.2]). Retinas
were washed, postfixed in 1% osmium, en bloc-stained in 2% uranyl
acetate, dehydrated in graded acetone and embedded in resin (Taab
Laboratories, Aldermaston, UK).
Light Damage and Rhodopsin Regeneration
Timp3S156C/S156C mice between 6 and 12 weeks of age were dark
adapted and subsequently exposed to diffuse white fluorescent light
for 2 hours with an intensity of 5,000 or 15,000 lux. Animals were
analyzed after a 24-hour period in darkness or after 14 days in the
light–dark cycle. Bleaching of rhodopsin was achieved by exposing
dark-adapted mice for 10 minutes to 5,000 lux of white light. Light was
switched off to allow metabolic rhodopsin regeneration in darkness.
Rhodopsin levels were determined as described.23
PCR Amplification and Sequence Determination
of RPE65
DNA was prepared from tail biopsy specimens and amplified with
primer pair RPE65/450A (5-ATA TTA AAT CAG CTC TGT AAG A-3)
and RPE65/450Rev (5-CAT TAC CAT CAT CTT CTT CCA-3) or with
primer pair RPE65/450C (5-ATA TTA AAT CAG CTC TGT AAG C-3)
and RPE65/450Rev. The first primer pair results in an amplicon of 150
bp when the substrate DNA encodes Met but not Leu at codon 450 of
RPE65. When a Leu is encoded at this position, PCR with primer pair
2 but not primer pair 1 results in the appropriate product.
Disc Shedding
Mice were kept individually in cages in a normal 12:12-hour light–dark
cycle (60 lux at cage level). Pupils were dilated as described earlier and
mice exposed to 13,000 lux for 1 hour at the beginning of the light
cycle. Retinal tissue was isolated after a 90-minute recovery period in
darkness and prepared for light microscopy, as described earlier.
Phagosomes were counted in 10 consecutive fields of 180 m length,
and the numbers were averaged. Means of six retinas were statistically
analyzed by an unpaired t-test.
RESULTS
Generation of Timp3/S156C Knock-in Mice
A construct containing the Ser156Cys mutation was generated
using site-directed mutagenesis and targeted into the murine
Timp3 locus through homologous recombination in ES cells
(Fig. 1a). In positive lines Cre recombinase was transiently
expressed to excise the neor cassette and mutant ES cells were
microinjected into C57BL/6 blastocysts, yielding two high-
percentage chimeric males. Progeny of 129/Sv and hybrid
C57BL/6x129/Sv background were assessed for genotype and
manifestation of the SFD phenotype. Germline transmission of
the correctly targeted Timp3S156C allele was confirmed by the
detection of a 3.3- and a 6.0-kb BamHI fragment in Southern
hybridizations (Figs. 1a, 1b and data not shown). RNA isolated
from kidney tissue that is known to express Timp3 abundantly
in adult mice,27 was analyzed by Northern blot analysis, detect-
ing the correct transcript sizes of the three known Timp3
isoforms in wild-type, heterozygous Timp3/S156C, and ho-
mozygous Timp3S156C/S156C mice (Fig. 1c). In addition, se-
quencing of RT-PCR products from eyecup total RNA with
primers flanking the S156C mutation in exon 5 of Timp3
demonstrated transcription of the Timp3S156C allele in both
heterozygous and homozygous mice (data not shown). Expres-
sion of the Timp3 protein was confirmed by Western blot
analysis of extracellular matrix extracts from fibroblast cultures




Sequential SLO was performed in two 14-month-old
Timp3/S156C mice and, for comparison, in two wild-type
animals (Fig. 2a). Analyses of the various planes of the posterior
pole, from the surface of the retina down to the RPE, did not
reveal any morphologic abnormalities in the Timp3/S156C
mice. ERG Ganzfeld examinations of five wild-type and six
Timp3/S156C mice showed no differences in either waveform
shape or signal amplitude over the entire intensity range (Fig.
2b and data not shown). The scotopic and photopic b-wave
amplitudes were recorded over a period of 2 years in four
mutant and four wild-type eyes, respectively (Fig. 2c). Al-
though there was a general decrease in amplitude over time in
both mutant and control animals, there was no sign of impaired
retinal function in Timp3/S156C mice at any age.
Electron Microscopic Analysis of the Retinal
Pigment Epithelium, Bruch’s Membrane,
and the Retina
For comparison of the ultrastructure, two animals each from
wild-type, heterozygous Timp3/S156C and homozygous
Timp3S156C/S156C mice were analyzed at the ages of 8 and 30
months, respectively. In both age groups, electron microscopy
revealed no alterations between wild-type and mutant mice in
the neuronal layers of the retina, including the inner nuclear
and ganglion cell layers and the photoreceptor inner and outer
segments.
In 8-month-old wild-type animals, the RPE showed no struc-
tural abnormalities (Figs. 3a–c). The apical processes of the
RPE cells were vertically and regularly aligned and in close
contact with the adjacent photoreceptor outer segments. The
labyrinth of the basal microvilli was compact and dense (Fig.
3c). In the Timp3/S156C mice, no alterations in the appear-
ance of the apical processes were observed in the major parts
of our electron microscopy specimen. In some areas (15%–20%
of areas analyzed), however, the vertical orientation was less
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strict and the distance between processes was increased at the
cellular bases (Fig. 3d). Next to Bruch’s membrane, a patchy
thinning of the layer of the basal microvilli was observed (Figs.
3e, 3f). In addition, the compact packing of the basal microvilli
was impaired and occasionally wide-open caverns extended
from the basal labyrinth into the cytoplasm of the cell (Figs.
3d–f). The thickness of Bruch’s membrane was in the general
range of 0.5 and 0.7 m. There was no significant difference
between wild-type and Timp3/S156C or Timp3S156C/S156C
mice (Figs. 3c, 3f, 3i). In the 8-month-old homozygous
Timp3S156C/S156C mice, the RPE processes facing the outer
segments of the photoreceptors were short and not vertically
elongated, but horizontally aligned near the cell bodies of the
RPE. Toward the photoreceptors, they were composed of
small, vesiculated structures that do not envelop the outer
segments (Fig. 3g). In areas where such abnormalities were
present, these vesiculated processes seemed to form a barrier
between the outer segments and the RPE. Moreover, severe
changes in thickness and compactness of the basal microvilli
appeared in the Timp3S156C/S156C mice. There was a general
derangement of the basal layer, with a loss of the palisade-like
orientation of the microvilli accompanied by a marked reduc-
tion in thickness (Fig. 3h) up to virtually a complete loss of the
entire labyrinth (Fig. 3i).
In 30-month-old control animals, the five-layered structure
of Bruch’s membrane was clearly visible (Figs. 4a–d), although
there was a general tendency of the thickness of the membrane
to be in the upper range of 0.8 m (Fig. 4b). The width of the
basal labyrinth was greatly reduced in these animals compared
with that in the 8-month-old wild-type mice. In some areas the
basal microvilli of the aged control animals were absent (Fig.
4d), resembling the findings in the 8-month-old homozygous
Timp3S156C/S156C mice (Fig. 3i). In both heterozygous and
homozygous 30-month-old mutant animals (Figs. 4e–l) the lay-
ering of Bruch’s membrane was still present (Figs. 4e, 4i) but
less clearly expressed, and a higher amount of granular debris
was accumulating in the inner layers of the extracellular mem-
brane (Figs. 4f, 4g, 4j). The overall thickness of Bruch’s mem-
brane varied from 0.5 (Fig. 4e) to 1.2 m (Fig. 4j). Similar to the
aged wild-type animals a layer of electron dense material oc-
curred proximal to the basement membrane in the heterozy-
gous mice (Figs. 4c, 4g, stars), although this layer was generally
more pronounced in the mutant animals (Figs. 4h, 4k, stars)
and in some instances reached into the soma of the RPE (Fig.
4k, asterisk). In areas where the microvilli labyrinth was com-
pletely lost the soma of the RPE was interspersed with large
caverns (Fig. 4l).
Western Blot Analysis
To test for altered levels of a selected number of retina and RPE
proteins, eyecup protein extracts were assayed with antibodies
directed against IRBP, RPE65, arrestin, and CRALBP. Similar
levels of protein were found in Timp3S156C/S156C and wild-type
mice (Fig. 5a).
Western blot analyses under nonreducing conditions (with-
out -ME) of extracellular matrix extracts derived from fibro-
blast cultures from patients with SFD carrying a heterozygous
Ser156Cys or a Ser181Cys mutation demonstrate the occur-
rence of higher-molecular-weight complexes specifically la-
beled by the human peptide antibody phAB#57 (Fig. 5b).
Protein extracts from murine Timp3S156C/S156C fibroblast cell
line ECM behave similarly and label higher-molecular-weight
complexes under nonreducing, but not under reducing, con-
ditions (Fig. 5b). In protein extracts from the RPE-choroid of
homozygous mice higher-molecular-weight complexes of sim-
ilar molecular weight (approximately 40–45 kDa) compared
with the ECM extracts are present (Fig. 5c). To test for Timp3
FIGURE 2. Macromorphologic and
electrophysiological evaluation of
Timp3/S156C mice. (a) Shown is a
representative sequence of images
obtained while adjusting the focus
from the retinal view (top row)
down to the RPE view (bottom row).
There was no macroscopic sign of
pathologic retinal morphology in
Timp3/S156C mice (left column)
compared with control animals
(right column). (b) Superposition of
the dark-adapted (scotopic, left col-
umn) and light-adapted (photopic,
right column) intensity series in a
Timp3/S156C and a wild-type mouse.
No waveform differences were ob-
served between control and mutant
mice. (c) Age-related changes of
scotopic (top traces) and photopic
(bottom traces) b-wave amplitudes
in Timp3/S156C mice up to 28
months of age. Boxes: 25% to 75%
quantile range; small crosses: the me-
dian of the Timp3/S156C data. Solid
lines: normal range is indicated by
the 5% and 95% quantiles of the con-
trol group. In comparison to the age-
matched control animals, there was
no sign of impaired retinal function
in Timp3/S156C mice at any age.
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levels in normal and homozygous knock-in mice, serial dilu-
tions of total protein extracts from RPE-choroid were labeled
with murine Timp3 antibody pmAB#50 (Fig. 5d). At 20 g of
total protein extracts, Timp3 was only weakly labeled in the
wild-type sample, whereas there was a stronger immunoreac-
tion in the mutant sample. Immunoreactivity was still observed
at 10 g of protein extracts in the mutant but not in the control
tissue.
Localization of Normal and Mutant Timp3 in the
Mouse Retina
To determine Timp3 localization in the normal and mutant
mouse retina, immunofluorescence labeling of Timp3/ and
Timp3S156C/S156C retinal sections with polyclonal antibody
pmAB#50 were performed (Figs. 6a, 6c). Prominent labeling of
Bruch’s membrane was observed in wild-type and homozygous
Timp3S156C/S156C retinas. There was also specific labeling of
the sclera and minor staining of the photoreceptor outer and
inner segments in both wild-type and mutant retinal sections
(Figs. 6a, 6c). The specificity of Timp3 immunolabeling was
demonstrated by addition of excess of Timp3 peptide antigen
during the labeling procedure, which completely abolished
immunopositivity of Bruch’s membrane and sclera, as well as
the minor site of labeling in the photoreceptor layer (Fig. 6b).
Similarly, in control studies with rabbit preimmune serum, no
immunolabeling was present in mouse retinal sections (data
not shown).
Effects of Light Exposure, Rhodopsin
Regeneration, and Disc Shedding
To assess the influence of the Timp3 mutation on retinal light
damage susceptibility, we exposed Timp3S156C/S156C and wild-
type mice to intense white light for 2 hours. Illumination with
5000 lux resulted in the abundant formation of pyknotic nuclei
and of apoptotic bodies in retinas of both mutant and wild-type
mice compared with dark-adapted control mice (Figs. 7b, 7f).
No differences were detected in the susceptibility to light
damage between wild-type and mutant retinas. A three times
higher dose of light (15,000 lux for 2 hours) increased the signs
of cell death with severely disrupted rod inner (RIS) and rod
FIGURE 4. Electron photomicrographs of the basal RPE labyrinth and
Bruch’s membrane in 30-month-old Timp3/ (a–d), Timp3/S156C
(e–h), and Timp3S156C/S156C (i–l) mice. Arrowhead: basement mem-
brane; () electron-dense material proximal to the basement mem-
brane. BV, basal microvilli; RPS, soma of the retinal pigment epithe-
lium; C, cavern. Bar, 0.5 m.
FIGURE 3. Electron photomicrographs of 8-month-old Timp3/,
Timp3/S156C, and Timp3S156C/S156C mice. (a–c) Wild-type mice
showed a normally developed RPE with elongated apical processes (b;
arrow) and a compact layer of basal microvilli (c). (d–f) Heterozygous
Timp3/S156C mice displayed localized disorientation of the apical
processes and reduction in thickness (e; marked with vertical lines)
and complexity (e, f) of the basal microvilli. Occasionally, caverns
protruded into the cytoplasm (f). (g–i) In Timp3S156C/S156C mice, the
elongation of the apical processes was disturbed, and the processes
were vesiculated toward the outer segments. The arrangement of the
basal microvilli was severely damaged (h) up to nearly a complete loss
of the basal structure (i). () Bruch’s membrane. AP, apical processes;
BV, basal microvilli; C, cavern; OS, outer segments; V, vesiculated
processes. Bar: (a, d, g) 1.0 m; (b, c, e, f, h, i) 0.5 m.
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outer segments (ROS; Figs. 7c, 7g). Fourteen days after the
exposure to 15,000 lux for 2 hours, the outer nuclear layer was
severely thinned and consisted of approximately one third of
the number of cells compared with the unexposed control.
ROS and RIS were almost completely absent (Figs. 7d, 7h).
Because susceptibility to light damage is at least partially
determined by the rate of rhodopsin regeneration in the visual
cycle28 and because the visual cycle may be influenced by the
composition and function of the extracellular matrix, we as-
sessed the rate of rhodopsin regeneration in Timp3S156C/S156C
mice. The regeneration rate in the visual cycle correlates with
the amino acid sequence of the RPE65 protein at position 450.
A leucine at this position, as found, for example, in BALB/c mice,
led to a fast regeneration with a rate constant of approximately
0.036/minute and, accordingly, to a high susceptibility to light
damage. In contrast, C57BL/6 mice, which have a methionine
at position 450 of the RPE65 protein, regenerate rhodopsin
four times slower, with a rate constant of 0.009/minute, and
have a low susceptibility to light damage.28 We determined the
DNA sequence of RPE65 in the Timp3S156C/S156C mice. All
mice tested (n  4) had a leucine at position 450 in the RPE65
protein. Conformably, the mice regenerated rhodopsin with a
rate constant of approximately 0.033/minute (Table 1) indicat-
ing that the Timp3 mutation did not significantly influence
regeneration of metabolic rhodopsin.
We also tested the influence of the mutation on light-
elicited disc shedding. Timp3S156C/S156C mice were raised in a
12:12-hour light–dark cycle with 60 lux at cage level in sepa-
rate cages for 10 days. Ninety minutes after light exposure to
13,000 lux for 1 hour, retinas were prepared and examined for
disc shedding. This treatment resulted in the dilation of ROS
(asterisk in Figs. 8b, 8c) and in a burst of disc shedding.29 The
shed material was phagocytosed by the RPE which led to an
increase of phagosomes when compared with dark-adapted
control retinas (Figs. 8a–c, arrows). The Timp3 mutation did
FIGURE 5. Western blot analyses of
normal and mutant TIMP3. (a) Pro-
tein levels were similar in wild-type
and Timp3S156C/S156C mice. Total
eyecup protein homogenates were
assayed for levels of IRBP, RPE65,
arrestin, and CRALBP. (b) Under non-
reducing conditions, ()-ME, addi-
tional higher-molecular-weight com-
plexes of TIMP3 were seen in ECM
extracts from fibroblast cultures of
patients with SFD carrying heterozy-
gously the Ser156Cys or Ser181Cys
mutation but not in control individu-
als (/). The phAB#57 antibody
was used. Similar protein complexes
were present in ECM preparations of
homozygous mice under nonreduc-
ing conditions, whereas under reduc-
ing conditions, ()-ME, these com-
plexes did not form. The pmAB#50
antibody was used. Note the non-
complexed mutant Timp3 in the homozygous Timp3S156C/S156C protein extracts under nonreducing conditions, suggesting that not all mutant
Timp3 participates in the formation of the higher-molecular-weight complexes. (c) Protein preparations from RPE-choroid tissue of wild-type
(/) and homozygous knock-in mice were electrophoretically separated under reducing and nonreducing conditions. Similar to the results in
ECM preparations, higher-molecular-weight complexes of Timp3 were formed under nonreducing conditions in the Timp3S156C/S156C protein
extracts. The pmAB#50 antibody was used. (d) Total protein extracts from RPE-choroid tissue of wild-type (/) and homozygous knock-in mice
(S156C/S156C) were serially diluted as indicated and labeled with murine antibody pmAB#50. Note the immunoreactivity at a total protein
concentration of 20 g and 10 g in the mutant preparations compared with the wild-type.
FIGURE 6. Immunofluorescence microscopy of Timp3 in retinal sec-
tions from 7-month-old wild-type (/) and homozygous (S156C/
S156C) mice. (a) Intense Timp3 immunolabeling of Bruch’s membrane
in wild-type. Some minor labeling was also present in the photorecep-
tor layer and the choroid. (b) Control, Timp3 immunolabeling in the
presence of excess competing Timp3 peptide. (c) Timp3 immu-
nolabling of a homozygous retinal section. Note the intense staining of
Bruch’s membrane similar to wild-type retina. NR, neuronal retina;
RPE, retinal pigment epithelium; BM, Bruch’s membrane.
FIGURE 7. Light damage analysis. Wild-type (a–d) or Timp3S156C/S156C
mice (e–h) were kept in darkness (a, e) or were exposed to 5,000 lux
(b, f) or 15,000 lux (c, d, g, h) of white light. After exposure, animals
were analyzed after 24 hours in darkness (b, c, f, g) or after a 24 hours
in darkness followed by a 14-day period in normal cyclic light (d, h).
Arrows: samples of pyknotic nuclei. Arrowheads: apoptotic bodies;
PE, pigment epithelium; ROS, rod outer segments; RIS, rod inner
segments; ONL, outer nuclear layer. Bar, 25 m.
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not influence disc shedding and phagocytosis, as judged from
similar numbers of phagosomes (P  0.3, unpaired t-test, n 
6) in the RPE of wild-type (10.1  2.5 phagosomes/180 m)
and Timp3S156C/S156C mice (8.8  2.1 phagosomes/180 m).
DISCUSSION
Elucidation of the mechanisms of human retinal disease has
been hampered by the scarcity of diseased material for mor-
phologic and functional studies, as well as by the availability of
such material only at advanced stages of the disease, when the
primary events of pathogenesis are likely to be obscured.
Recent advances allowing the generation of mouse models for
retinal disease have helped to overcome these obstacles and
facilitate the detailed analysis of the primary retinal disease.
With the goal of creating a mouse model for SFD, we have used
a gene-targeting strategy to create knock-in mice carrying a
Ser156Cys mutation in the endogenous murine Timp3 gene.
This mutation is homologous to one initially identified in a
large German-Czech SFD pedigree with onset of symptoms in
affected individuals generally in their early 30s.12
Patients with SFD with heterozygous mutations in the
TIMP3 gene typically experience loss of central vision in
midlife, with ocular examination showing disciform scars of
the macula due to neovascularization and atrophy. Progressive
atrophy leads to later loss of peripheral vision. The Ganzfeld
ERG, which is a valuable indicator of retinal function below the
ganglion cell level, may initially be normal in patients with SFD,
but usually becomes subnormal in more advanced stages of the
disease.13 Variability in phenotype has been reported, with
some patients showing significantly later onset, preservation of
the peripheral retina, and normal ERGs.15 ERGs recorded in
heterozygous and homozygous Timp3 knock-in mice under
scotopic and photopic conditions indicate that retinal function
is not affected by the presence of mutated Timp3 during the
life span of mice. Similarly, the macromorphologic in vivo
analysis using SLO did not reveal any gross abnormalities; in
particular, there were no signs of the secondary fundus com-
plications that are usually observed in advanced stages of
human disease.
There are few reports on the histopathology of SFD in
humans.2,3,30 Using light and electron microscopy Capon et
al.2 and Chong et al.3 have described morphologically similar
deposits of granular–floccular material between the basement
membrane of the RPE and the inner collagenous layer of
Bruch’s membrane. In the elastic layer, they noted irregulari-
ties such as breaks and thickening, whereas the outer collage-
nous layer of Bruch’s membrane appeared relatively normal. In
addition, there was photoreceptor loss, disorganization of the
RPE, and discontinuity and general thickening of Bruch’s mem-
brane. Electron microscopy of middle-aged retinas of both
heterozygous and homozygous knock-in mice showed distinct
abnormalities in the RPE, specifically affecting the thickness
and organization of the basal microvilli. At this age, no abnor-
malities of Bruch’s membrane comparable to those seen in
late-stage human disease were noted. At 30 months of age,
however, mutant (heterozygous and homozygous) animals
showed more pronounced changes accentuated by increased
thickening of Bruch’s membrane and marked disturbances of
the inner collagenous layer. Moreover, in many areas, the basal
membrane of the RPE assumed a blurry appearance accompa-
nied by a complete breakdown of the microvilli labyrinth. In
those areas, large caverns were forming in the soma of the RPE.
It should be emphasized that the human SFD eyes available for
examination are generally obtained from donors of advanced
age and with a long-time history of disease, making it difficult,
if not impossible, to distinguish between primary pathologic
features and secondary changes. So far, pathologic features of
early SFD have not been documented in humans. At 30 months
of age, the mice are near the end of their life spans in captivity
but may be manifesting only the early stages of disease. If this
were the case, our findings in the knock-in mouse would imply





(% of maximum) Comment
Dark 0.433/0.460 0.447 (100) Maximum value; dark adaption for 16 hours
Immediately after illumination 0.067 0.067 (15) Illumination with 5000 1ux for 10 minutes
(standard protocol for bleaching)
Regeneration
5 minutes 0.075/0.100 0.088 (20) After bleach, mice recovered in dark for 5
minutes before sample preparation
15 minutes 0.192/0.210 0.201 (45) After bleach, mice recovered in dark for 15
minutes before sample preparation
30 minutes 0.267/0.330 0.299 (67) After bleach, mice recovered in dark for 30
minutes before sample preparation
* At time of sample preparation.
† Rate constant for rhodopsin regeneration is approximately 0.033/min and thus very similar to BALB/c mice.28
FIGURE 8. Disc shedding. Dark adapted wild-type (a, b) and age-matched Timp3S156C/S156C mice (c) were exposed to 13,000 lux of white light
(b, c) or kept in darkness (a) as a control. After a recovery period of 90 minutes in darkness, retinas were analyzed. Arrows: phagosomes; (✻) dilated
ROS. PE, pigment epithelium; ROS, rod outer segments. Bar, 10 m.
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that the primary site of SFD disease is at the junction of RPE and
Bruch’s membrane, with early manifestations in the basal lab-
yrinth and disturbances in the inner collagenous layer of
Bruch’s membrane. Choroidal neovascularization and atrophic
changes as seen in humans may then represent delayed reac-
tions of the ECM–RPE disturbances that do not become mani-
fest in the normal life span of the mouse.
Studies in both human and mouse have determined the RPE
to be the site of normal TIMP3 mRNA expression.31–33 Fur-
thermore, immunohistochemistry has localized the TIMP3 pro-
tein to Bruch’s membrane in normal human eyes33,34 and in
the eyes of a donor with SFD.3 Another report localized TIMP3
within Bruch’s membrane but also at the level of the RPE,
raising the additional possibility that the protein may also be
secreted at the apical surface of the RPE cells.35 Our immuno-
fluorescence labeling studies in mouse retinal sections are in
excellent agreement with the previous studies and show that
Timp3 immunoreactivity is strongly associated with Bruch’s
membrane but also, to a minor extent, with the photoreceptor
layer. The availability of the homozygous knock-in mouse pro-
vides the unique opportunity to analyze mutant Timp3 expres-
sion without the interference of cross-immunoreactivity to the
normal protein. Our results show that mutant Timp3 localiza-
tion within the retina is identical with that in wild-type retina.
This strongly suggests that the Ser156Cys mutation does not
influence site-specific binding to the extracellular matrix (i.e.,
Bruch’s membrane), thus rejecting an earlier notion that a
possible mechanism of disease may stem from an aberrant
location of mutant Timp3.33
In an alternative hypothesis Langton et al.11,16 suggest that
an excess, rather than an absence or deficiency, of functional
protein may underlay the pathogenesis of SFD. In a heterolo-
gous expression system, they have shown, in reverse zymo-
gram assays, that mutant TIMP3 forms higher-molecular-weight
complexes that retain an inhibitory effect on MMPs.11,16 Ac-
cording to the model, the functional higher-molecular-weight
Timp3 complexes may be less prone to degradation and thus
may accumulate in Bruch’s membrane over time. Subse-
quently, proper ECM remodeling would probably be impaired,
leading to the known findings in Bruch’s membrane. Our
results in the knock-in mice provide several lines of evidence
supporting the proposed model. First, we show that, similar to
normal Timp3, the mutant form is strongly associated with
Bruch’s membrane. From immunofluorescence labeling studies
there is no indication that the mutant protein may be displaced
within the retinal tissues. Second, the higher-molecular-weight
complexes could indeed be of direct relevance to SFD patho-
genesis, because these complexes are not only formed in ECM
extracts of in vitro cultured fibroblasts but are also present in
the murine eye. Third, although accurate quantification of
normal and mutant Timp3 in Bruch’s membrane is difficult, our
results indicate that there may be a relative increase in Timp3
levels in the mutant eye, although these latter findings must be
further substantiated. It is not clear at this point whether there
is an upregulation of Timp3 expression on the transcript or
protein level or whether the mutation is directly or indirectly
involved in Timp3 stability and turnover rate. Last, our studies
demonstrate that early signs of disease in the mouse are exclu-
sively found in cellular and extracellular structures tightly as-
sociated with mutant Timp3 localization, further supporting a
direct role of the mutant protein in primary changes at the
level of Bruch’s membrane and the RPE.
We further used the mouse model to explore whether
mutant Timp3 directly or indirectly increases the rate of cell
death in the retina in response to light exposure. One possible
mechanism is induction of apoptosis. TIMP3 has been shown
to activate cell death in carcinoma cell lines,36 and its overex-
pression promotes apoptosis in smooth muscle cells.37 This
activity has been localized to the N terminus of the protein and
appears to be dependent on inhibition of MMP.38 Examination
of susceptibility to light damage revealed no difference be-
tween the retinas of wild-type and homozygous mutant mice.
Retinal light damage is influenced by the chromophore rho-
dopsin, which controls photon absorption.39 The rate of re-
generation after bleaching is a major determinant of the sus-
ceptibility to light damage28 and has been found to be
abnormal in at least one patient with SFD.40 Metabolic rhodop-
sin regeneration remained uninfluenced by the Timp3 muta-
tion in our mouse model. This is consistent with the observa-
tion of normal levels of the retinal proteins RPE65 and CRALBP
as well as IRBP, which is expressed in the ECM. In addition,
mutant mice showed similar levels of arrestin, which is in-
volved in phototransduction. Exposure to bright light not only
induces photoreceptor apoptosis but also potentiates the shed-
ding of ROS tips (shedding burst), which usually follows a
circadian rhythm with its peak at the beginning of the light
phase.29 Shedding and phagocytosis of ROS tips by the cells of
the RPE involves the ECM, and therefore could be affected by
Timp3 gene mutations; however, in the homozygous mutant
mice, we found no abnormalities in these processes.
The generation of the Timp3S156C mouse model promises
to be a helpful tool to further investigate the primary mecha-
nisms of SFD. It is interesting to note that the mutant mouse
displays a less severe phenotype than do patients with SFD,
although the abnormal murine Timp3 appears to have the same
biochemical characteristics as the human protein. It is unlikely
that TIMP3, which is highly conserved between human and
mouse (96% amino acid sequence identity) displays functional
differences in the two species. A minor phenotype in the
mouse may, however, be caused by a greater developmental
plasticity in the mouse eye or by other adaptive mechanisms
capable of compensating the deleterious effects of the intro-
duced mutation. Examples illustrating such compensatory
mechanisms are scarce in the literature but have been docu-
mented.41–43 Alternatively, the development of pathologic fea-
tures may be influenced by the genetic background and may
require intervention strategies for the symptoms to manifest.44
In fact, the observation that vitamin A supplementation re-
verses the night blindness in patients with SFD suggests that
nutritional factors may affect SFD pathophysiology.13 To this
end, we have initiated long-term studies challenging the Timp3
knock-in mice by vitamin A depletion. Similarly, isogenic
breeding of the Timp3 knock-in mutation onto defined mouse
backgrounds may produce a more severe phenotype, possibly
expressing the typical secondary manifestations of SFD, such as
subretinal neovascularization and atrophy of the choriocapil-
laris.
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